The Genetics Local Specialty Group (LSG) is led by Dr Bill Newman (pictured), a clinical senior lecturer at the University of Manchester and honorary consultant at St Mary’s Hospital, part of Central Manchester University Hospitals NHS Foundation Trust.
The LSG has interests in the diagnosis and treatment of a range of inherited disorders, pharmacogenetics (the study of genetic variants that predict response to medication) and using different technologies to identify novel disease causing genes. It works closely with a number of other LSGs in the development of novel treatments for different conditions.
It also has close ties with the NIHR Manchester Biomedical Research Centre, which specialises in genetics and developmental medicine.
Two major studies that the LSG are currently recruiting study participants to are:
the PROCAS study, which is a collaboration with the Cancer LSG, that is a looking at genetic factors and information from mammograms to predict the risk of women developing breast cancer and is lead by Prof Gareth Evans.
DDD (Deciphering Developmental Delay) is a national study led by a team of researchers at the Sanger Centre in Cambridge to use new technologies to try to work out the reasons for learning disability inchildren.
If you would like more information on our work please contact Dr Newman.